WO2024236504 - SEQUENCES AND METHODS FOR DELIVERY OF DNA AND RNA
National phase entry is expected:
Publication Number
WO/2024/236504
Publication Date
21.11.2024
International Application No.
PCT/IB2024/054730
International Filing Date
15.05.2024
Title **
[English]
SEQUENCES AND METHODS FOR DELIVERY OF DNA AND RNA
[French]
SÉQUENCES ET PROCÉDÉS D'ADMINISTRATION D'ADN ET D'ARN
Applicants **
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors
CONDORI, Jose
CHOI, Vivian
Priority Data
63/502,389
15.05.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3947 | |
| EPO | Filing, Examination, Granting | 29625 | |
| Japan | Filing, Examination, Granting | 3277 | |
| South Korea | Filing, Examination, Granting | 4119 | |
| USA | Filing, Examination, Granting | 17640 |
Total:
58,608
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to sequences and methods for delivery of DNA and RNA using, for example, DNA nuclear targeting sequences (DTSs). These sequences provide more efficient delivery of target DNA and RNA into cells. These sequences are also particularly effective for targeting liver cells, for example, for treatment of inherited liver and systemic disorders, as well as acquired genetic disorders, and also serve as a treatment method for numerous diseases and disorders.[French]
La présente invention concerne des séquences et des procédés d'administration d'ADN et d'ARN à l'aide, par exemple, de séquences de ciblage nucléaire d'ADN (DTS). Ces séquences permettent une administration plus efficace d'ADN et d'ARN cibles dans des cellules. Ces séquences sont également particulièrement efficaces pour cibler des cellules hépatiques, par exemple, pour le traitement de troubles hépatiques et systémiques hérités, ainsi que des troubles génétiques acquis, et servent également de procédé de traitement pour de nombreuses maladies et troubles.